Table 3.
Characteristic | Univariate analysis | Multivariable analysis | ||
---|---|---|---|---|
Odds ratio (95% CI) | p Value | Odds ratio (95% CI) | p Value | |
Age at laparoscopy | ||||
>60 y | 1.00 (ref) | 1.00 (ref) | ||
≤60 y | 1.76 (1.25–2.47) | 0.001 | 1.82 (1.19–2.79) | 0.006 |
Tumor location | ||||
Proximal | 1.00 (ref) | 1.00 (ref) | ||
Distal | 2.87 (2.07–4.00) | <0.001 | 2.78 (1.84–4.21) | <0.001 |
Tumor size | ||||
≤20 mm (T1) | 1.00 (ref) | 1.00 (ref) | ||
21 to 40 mm (T2) | 3.10 (1.85–5.48) | <0.001 | 2.33 (1.25–4.32) | 0.008 |
>40 mm (T3) | 6.40 (3.69–11.65) | <0.001 | 2.28 (1.14–4.56) | 0.019 |
Anatomical resectability | ||||
Resectable | 1.00 (ref) | 1.00 (ref) | ||
BR/LA | 2.12 (1.47–3.13) | <0.001 | 1.55 (0.96–2.51) | 0.07 |
Indeterminate lesion on imaging | ||||
No | 1.00 (ref) | 1.00 (ref) | ||
Yes | 10.63 (7.11–16.03) | <0.001 | 6.84 (4.19–11.17) | <0.001 |
Serum CA 19-9 | ||||
Normal (<35 U/mL) | 1.00 (ref) | 1.00 (ref) | ||
Nonsecretor | 2.04 (0.98–4.03) | 0.046 | 1.69 (0.73–3.92) | 0.22 |
Elevated (≥35 U/ml) | 2.29 (1.55–3.45) | <0.001 | 1.69 (1.02–2.81) | 0.042 |
Serum CEA | ||||
Normal (≤3.0 ng/mL) | 1.00 (ref) | 1.00 (ref) | ||
Elevated (>3.0 ng/mL) | 1.66 (1.08–2.55) | 0.022 | 1.19 (0.72–1.99) | 0.49 |
Neoadjuvant therapy | ||||
No | 1.00 (ref) | 1.00 (ref) | ||
Yes | 0.60 (0.43–0.83) | 0.002 | 0.72 (0.47–1.10) | 0.13 |
Peritoneal CA 19-9 | ||||
Normal (<5 U/mL) | 1.00 (ref) | 1.00 (ref) | ||
Elevated (≥5 U/mL) | 2.89 (1.76–4.73) | <0.001 | 1.76 (0.95–3.27) | 0.07 |
Peritoneal CEA | ||||
Normal (<0.7 ng/mL) | 1.00 (ref) | 1.00 (ref) | ||
Elevated (≥0.7 ng/mL) | 6.74 (3.72–12.21) | <0.001 | 2.94 (1.45–5.93) | 0.003 |
Data presented after multiple imputation for serum CEA, peritoneal CA 19-9, and peritoneal CEA.
BR/LA, borderline resectable/locally advanced.